Ftse Mib
34.717,28
0,56%
DAX
20.399,16
0,25%
S&P 500
6.084,19
0,82%
NASDAQ
20.034,89
1,77%
Bitcoin
101.769,34
5,27%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ TFF Pharmaceuticals Inc (TFFP) TFF Pharmaceuticals Inc (TFFP) Notizie

TFF Pharmaceuticals Inc

TFFP
0,117
-0,1853 (-61,30%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:50:34
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/12/202422:05EDGAR2Form PRE 14A - Other preliminary proxy statements
10/12/202422:05EDGAR2Form 8-K - Current report
20/11/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202422:20EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
14/11/202422:15EDGAR2Form 8-K - Current report
14/11/202422:15GLOBETFF Pharmaceuticals Announces It Will Wind Down Operations
26/9/202413:00GLOBETFF Pharmaceuticals’ Technology Generates Superior..
11/9/202413:00GLOBETFF Pharmaceuticals Partners with Emory University and BARDA..
10/9/202413:00GLOBETFF Pharmaceuticals Announces Positive Preclinical Data from..
03/9/202414:00GLOBETFF Pharmaceuticals to Present at the H.C. Wainwright 26th..
14/8/202422:05EDGAR2Form 8-K - Current report
14/8/202422:05GLOBETFF Pharmaceuticals Reports Second Quarter Financial Results..
14/8/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202414:00EDGAR2Form 8-K - Current report
08/7/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/7/202423:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/6/202423:29EDGAR2Form 8-K - Current report
17/5/202422:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/5/202422:05EDGAR2Form 8-K - Current report
14/5/202422:04EDGAR2Form 8-K - Current report
14/5/202422:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
19/12/202312:07EDGAR2Form 8-K - Current report
15/12/202322:06EDGAR2Form 8-K - Current report
Apertura: 0,214 Min: 0,1551 Max: 0,214
Chiusura: 0,3023

La tua Cronologia

NASDAQ
TFFP
TFF Pharmaceuticals
BOV
BRKM5
BRASKEM PNA
DBI
I8N1
INXTRUSA BIFSRI 1C
COIN
BASICUST
BASIC Token
COIN
WAYYETH
Bitway
TG
A4HC
Amundi Index Solutions
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network